Bio-Startups
Dental care startup Smiles.ai rebrands as Dezy, plans to clock Rs 300 Cr by FY25
Having strengthened its foothold as a premium specialist in the dental care...
Treace Medical Concepts Acquires Patient-Specific Instrumentation Technology for Foot and Ankle Surgeries
Treace Medical Concepts, Inc., a medical technology company driving a funda...
Elicio Therapeutics Successfully Merges with Angion Biomedica
Elicio Therapeutics, a clinical-stage biotechnology company developing a pi...
AtomVie Global Radiopharma Secures $90M for Facility Buildout
AtomVie Global Radiopharma Inc., a global-leading CDMO for the GMP manufact...
Telesis Bio Secures Financing of $28.0 Million
Telesis Bio Inc., a leader in molecular biology automation solutions for mu...
Nykode Therapeutics and Roche Collaborate to Evaluate VB10.16 and anti-PD-L1 Combination in Advanced Cervical Cancer Trial
Nykode Therapeutics, a clinical-stage biopharmaceutical company dedicated t...
Palette Life Sciences Launches Barrigel Center of Excellence Program Designations
Palette Life Sciences, a fully-integrated global life sciences company dedi...
Larkspur Biosciences to Present Breakthrough Innovations at the 2023 BIO International Convention
Larkspur Biosciences is building the next precision immunotherapies to outs...
Trethera Secures $2M NCI Grant for Biomarker Advancement in Phase 1 Trial
Trethera Corporation, a clinical stage biopharmaceutical company committed ...
Awshad Ventures into Mushroom Wellness Market, Launches Calmashroom CBD and Cordyceps Capsules
A New Delhi-based medical cannabis wellness start-up Awshad has now venture...
Australian startup Cyteph secures $1.5 M for brain cancer immunotherapy trial
Cyteph, a spin-out biotechnology company from QIMR Berghofer Medical ...
C-CAMP receives CSR support from Cytiva to foster early-stage innovations in India
Bengaluru-based Centre for Cellular and Molecular Platforms (C-CAMP) has re...
AstriVax Receives €2.5M Grant to Advance Vaccine Platform
AstriVax is pleased to announce that it has been selected for funding by Fl...
FDA Approves Lexicon's INPEFA (sotagliflozin) for Heart Failure
Lexicon Pharmaceuticals, Inc. today announced that the U.S. Food and Drug A...
TScan Therapeutics Successfully Prices $140 Million Public Offering
TScan Therapeutics, Inc., a clinical-stage biopharmaceutical company focuse...
Sunstone Therapies' Psilocybin Therapy Shows Long-Term Benefits for MDD in Cancer Patients: ASCO Study
Sunstone Therapies, a leader in the development of clinical trials and the ...
Cullinan Oncology to Present First Monotherapy Clinical Data for CLN-619, a Novel Anti-MICA/B Antibody, at ASCO 2023
Cullinan Oncology, Inc., a biopharmaceutical company focused on modality-ag...
Tempest Presents Phase 1 Data on TPST-1495 in Advanced Cancers at ASCO
Tempest Therapeutics, Inc., a clinical-stage oncology company developing fi...
